Drawing for ANGEL TEARS

USPTO serial 75289609

ANGEL TEARS

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
SAPPENFIELD, ANN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ANGEL TEARS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MICHAEL D HOOL

MICHAEL D HOOL MARISCAL, WEEKS, MCINTYRE& FRIEDLANDER, PA2901 N CENTRAL AVE STE 200PHOENIX, AZ 85012

Goods and services

ClassDescriptionStatusFirst use
003baby care products, namely, lotion, skin cream, non-medicated skin ointment, bath soap, powder and shampooABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 22, 1999OP.TOPPOSITION TERMINATED NO. 999999—
Feb 22, 1999OP.SOPPOSITION SUSTAINED NO. 999999—
Feb 22, 1999ABN5ABANDONMENT - AFTER PUBLICATION—
Apr 3, 1998OP.IOPPOSITION INSTITUTED NO. 999999—
Dec 29, 1997ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 25, 1997PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 24, 1997NPUBNOTICE OF PUBLICATION—
Sep 25, 1997CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 22, 1997DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance